A Study to Assess the Tolerability of a Single Dose of STX107 in Adults With Fragile X Syndrome

NCT01325740 · clinicaltrials.gov ↗

PHASE2

Phase

SUSPENDED

Status

16

Enrollment

INDUSTRY

Sponsor class

Stopped pending further evaluation

Conditions

Fragile X Syndrome

Interventions

DRUG: STX107

Sponsor

Seaside Therapeutics, Inc.